← FDA DRUG APPROVALS

FDA ANDA · ANDA083346

ISOPROTERENOL HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA083346
TYPE
ANDA
ORIGINAL APPROVAL
1975-07-15
LATEST ACTION
2000-03-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ISOPROTERENOL HYDROCHLORIDEDiscontinued
ISOPROTERENOL HYDROCHLORIDE 0.2MG/ML · INJECTABLE · INJECTION

Approval history

2000-03-08Labeling · Supplement 27AP
1997-01-29Labeling · Supplement 28AP
1995-02-23Manufacturing (CMC) · Supplement 26AP
1992-06-01Labeling · Supplement 25AP
1991-02-05Manufacturing (CMC) · Supplement 24AP
1989-05-02Labeling · Supplement 23AP
1986-06-13Manufacturing (CMC) · Supplement 19AP
1986-06-13Manufacturing (CMC) · Supplement 21AP
1986-06-13Manufacturing (CMC) · Supplement 20AP
1982-10-05Manufacturing (CMC) · Supplement 15AP
1982-05-24Manufacturing (CMC) · Supplement 10AP
1975-07-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →